These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 27310371)

  • 1. Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway.
    Carpino G; Nobili V; Renzi A; De Stefanis C; Stronati L; Franchitto A; Alisi A; Onori P; De Vito R; Alpini G; Gaudio E
    PLoS One; 2016; 11(6):e0157246. PubMed ID: 27310371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease.
    Nobili V; Carpino G; Alisi A; De Vito R; Franchitto A; Alpini G; Onori P; Gaudio E
    PLoS One; 2014; 9(2):e88005. PubMed ID: 24505350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis.
    Ni Y; Zhuge F; Nagashimada M; Ota T
    Nutrients; 2016 Jun; 8(7):. PubMed ID: 27347998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease.
    Luo W; Xu Q; Wang Q; Wu H; Hua J
    Sci Rep; 2017 Mar; 7():44612. PubMed ID: 28300213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
    Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
    J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation.
    Yao J; Zhou CS; Ma X; Fu BQ; Tao LS; Chen M; Xu YP
    World J Gastroenterol; 2014 Oct; 20(39):14430-41. PubMed ID: 25339829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic Sleeve Gastrectomy Improves Nonalcoholic Fatty Liver Disease-Related Liver Damage in Adolescents by Reshaping Cellular Interactions and Hepatic Adipocytokine Production.
    Nobili V; Carpino G; De Peppo F; Caccamo R; Mosca A; Romito I; Overi D; Franchitto A; Onori P; Alisi A; Gaudio E
    J Pediatr; 2018 Mar; 194():100-108.e3. PubMed ID: 29198531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
    Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
    J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages in Nonalcoholic Fatty Liver Disease: A Role Model of Pathogenic Immunometabolism.
    Krenkel O; Tacke F
    Semin Liver Dis; 2017 Aug; 37(3):189-197. PubMed ID: 28847030
    [No Abstract]   [Full Text] [Related]  

  • 11. Ankaflavin ameliorates steatotic liver ischemia-reperfusion injury in mice.
    Yang HJ; Tang LM; Zhou XJ; Qian J; Zhu J; Lu L; Wang XH
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):619-25. PubMed ID: 26663010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease.
    Stacchiotti A; Favero G; Lavazza A; Golic I; Aleksic M; Korac A; Rodella LF; Rezzani R
    PLoS One; 2016; 11(1):e0148115. PubMed ID: 26824477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress.
    Carpino G; Pastori D; Baratta F; Overi D; Labbadia G; Polimeni L; Di Costanzo A; Pannitteri G; Carnevale R; Del Ben M; Arca M; Violi F; Angelico F; Gaudio E
    Sci Rep; 2017 Nov; 7(1):15756. PubMed ID: 29150621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered gut-liver axis and hepatic adiponectin expression in OSAS: novel mediators of liver injury in paediatric non-alcoholic fatty liver.
    Nobili V; Alisi A; Cutrera R; Carpino G; De Stefanis C; D'Oria V; De Vito R; Cucchiara S; Gaudio E; Musso G
    Thorax; 2015 Aug; 70(8):769-81. PubMed ID: 26069285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis.
    Wang X; Hausding M; Weng SY; Kim YO; Steven S; Klein T; Daiber A; Schuppan D
    Antioxid Redox Signal; 2018 Jan; 28(2):87-109. PubMed ID: 28635324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a.
    Wang S; Song K; Srivastava R; Dong C; Go GW; Li N; Iwakiri Y; Mani A
    FASEB J; 2015 Aug; 29(8):3436-45. PubMed ID: 25917329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
    Hirsova P; Ibrahim SH; Krishnan A; Verma VK; Bronk SF; Werneburg NW; Charlton MR; Shah VH; Malhi H; Gores GJ
    Gastroenterology; 2016 Apr; 150(4):956-67. PubMed ID: 26764184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural products that target macrophages in treating non-alcoholic steatohepatitis.
    Li CL; Zhou WJ; Ji G; Zhang L
    World J Gastroenterol; 2020 May; 26(18):2155-2165. PubMed ID: 32476782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice.
    Hoo RL; Lee IP; Zhou M; Wong JY; Hui X; Xu A; Lam KS
    J Hepatol; 2013 Feb; 58(2):358-64. PubMed ID: 23108115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells.
    Hu M; Kurobe M; Jeong YJ; Fuerer C; Ghole S; Nusse R; Sylvester KG
    Gastroenterology; 2007 Nov; 133(5):1579-91. PubMed ID: 17983805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.